GM1 gangliosidosis is an autosomal recessive disorder caused by the deficiency of lysosomal acid hydrolase ß-galactosidase (ß-Gal). It is one of the most frequent lysosomal storage disorders in Brazil, with an estimated frequency of 1:17,000.
R.C. Balestrin +6 more
doaj
Novel Galactosidase-Beta-1 Variant in Infantile GM1 Gangliosidosis: A Case Report. [PDF]
Srivastava P +5 more
europepmc +1 more source
Neural stem cells for disease modeling and evaluation of therapeutics for Tay-Sachs disease [PDF]
et al,, Jiang, Xuntian, Ory, Daniel S
core +1 more source
Clinical, Radiological, and Genetic Profiles of Eight Patients with Combined Dystonic Manifestation of Type-III GM1 Gangliosidosis: A Video Case Series from India. [PDF]
Roy S +9 more
europepmc +1 more source
Correction: Vyas et al. Efficacy of Adeno-Associated Virus Serotype 9-Mediated Gene Therapy for AB-Variant GM2 Gangliosidosis. <i>Int. J. Mol. Sci.</i> 2023, <i>24</i>, 14611. [PDF]
Vyas M +9 more
europepmc +1 more source
Impact of Sinbaglustat on Neurons of the Medial Nucleus of the Trapezoid Body in a Murine Model of Human G<sub>M1</sub>-Gangliosidosis. [PDF]
Jubran L +6 more
europepmc +1 more source
Editorial: Brain injury and neurodegenerative diseases: imaging and mechanisms
Zhuonan Wang +3 more
doaj +1 more source
Burden of caregiving of individuals with GM1 and GM2 gangliosidoses in the United States: a qualitative study. [PDF]
Rodriguez MB +8 more
europepmc +1 more source
Regulation of lysosomal ion homeostasis by channels and transporters [PDF]
core +1 more source
3D bioprinted neural scaffolds: a transformative avenue for GM2 gangliosidosis therapy. [PDF]
Sheikh M +4 more
europepmc +1 more source

